Robert E. Conway Elected Chairman Of ARCA biopharma Board Of Directors
6/9/2014 11:20:18 AM
ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that Robert E. Conway, has been elected Chairman of the Company’s Board of Directors. He serves on the Audit and Compensation Committees of the Board of Directors.
Help employers find you! Check out all the jobs and post your resume.
comments powered by